NCT05010148View on ClinicalTrials.gov

A Clinical Trial of Intravenous Lidocaine After Spinal Surgery to Prevent Delirium and Reduce Pain

PHASE3RecruitingINTERVENTIONAL
Enrollment

278

Participants

Timeline

Start Date

September 17, 2021

Primary Completion Date

September 30, 2027

Study Completion Date

September 30, 2027

Conditions
Postoperative DeliriumPostoperative PainSpinal Fusion
Interventions
DRUG

Lidocaine IV

Intravenous lidocaine will be given at 1.33mg/kg/hr (adjusted body weight) for 48 hours following major spinal surgery

DRUG

Placebo

D5 water given at an equivalent ml/hr as intravenous lidocaine (treatment arm) for 48 hours following major spinal surgery

Trial Locations (1)

94143

RECRUITING

University of California, San Francisco, San Francisco

All Listed Sponsors
lead

University of California, San Francisco

OTHER